Physicians in the US, Germany, and France show gaps in their knowledge of the treatment of of refractory/relapsed chronic ...

The impact alopecia areata (AA) has on patients' health-related quality of life (HRQOL) may not be accurately measured with ...

Clinical decision-making can be difficult for patients with SMA due to the lack of clinical trials comparing treatment ...

On this episode of Managed Care Cast, we're talking with the author of a study published in the September 2024 issue of The ...

Results show that cognitive decline, combined with factors like smoking, obesity, and chronic health conditions, sharply ...

The US health care system is underperforming despite high spending, and reform is needed in areas like insurance coverage, ...

September 9th 2024EP. 1: The Impact of CRM Diseases in the US: Burden, Prevalence, and Obesity A panel of experts examines the impact of cardiometabolic diseases in the United States, focusing on ...

Coverage from the Institute for Value-Based Medicine session at Ohio State University. This article will appear in the ...

The positive phase 3 results showed improved lung function with nerandomilast vs placebo at 52 weeks in idiopathic pulmonary ...

Dr JT Lew Explores the Barriers to MS Medication Access ...

Researchers from Bulgaria conduct an analysis of the potential for therapeutic vaccines in by comparing testing results for ...

Panelists discuss how type 2 inflammatory diseases, such as asthma, atopic dermatitis, and chronic rhinosinusitis, can significantly impair patients’ quality of life through persistent symptoms and ...